Table 1

Comparisons between the Solitaire thrombectomy and Penumbra suction thrombectomy groups

Solitaire group (n=13)Penumbra group (n=18)p Value
Age68.9±10.466.4±11.40.543
Male (n (%))7 (53.8)14 (77.8)0.247
Presentation time (min)231.2±191.5127.2±94.20.089
Initial NIHSS27.3±11.021.3±9.70.120
Hypertension (n (%))7 (53.8)8 (44.4)0.722
Diabetes mellitus (n (%))2 (15.4)10 (55.6)0.032*
Smoker (n (%))3 (23.1)12 (66.7)0.029*
Alcohol user ((n (%))3 (23.1)12 (66.7)0.029*
A Fib (n (%))6 (46.2)8 (44.4)1.000
Dyslipidemia (n (%))1 (7.7)18 (100)0.000*
Total cholesterol (mg/dL)191.5±55.5155.1±26.80.044*
Prior stroke (n (%))3 (23.1)15 (83.3)0.001*
Cardiogenic embolism (n (%))9 (69.2)10 (55.6)0.579
IV thrombolysis (n (%))5 (38.5)9 (50)0.717
Time to treatment (min)117.4±57.0109.2±65.40.720
Procedure time (min)101.9±41.462.3±34.80.044*
Successful recanalization11 (84.6)18 (100)0.168
Complete recanalization3 (23.1)13 (72.2)0.015*
NIHSS on discharge17.6±15.416.4±14.00.827
mRS on discharge3.5±2.23.7±1.80.779
mRS at 3 months3.6±2.63.3±2.60.726
Good outcome at 3 months5 (38.5)8 (44.4)1.000
Poor outcome at 3 months7 (53.8)8 (44.4)0.722
  • *p<0.05.

  • Presentation time=time interval from stroke symptom onset to hospital presentation.

  • Procedure time=time interval from commencement to the end of the procedure.

  • Successful recanalization=final TICI score of 2b or 3.

  • Complete recanalization=final TICI score of 3.

  • Good outcome at 3 months=patients with mRS scores of 0, 1, and 2, 3 months after their procedures.

  • Poor outcome at 3 months=patients with mRS scores of 5 and 6, 3 months after their procedure.

  • A Fib, atrial fibrillation; IV thrombolysis, intravenous thrombolytic therapy using recombinant tissue plasminogen activator; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TICI, Thrombolysis in Cerebral Infarction.